ReviewCentral nervous system agents in medicinal chemistry2024

Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease.

Priya P Shejul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.